Kaprex® by metagenics provides a safer option for effective joint relief. This proprietary combination of selected plant components influences kinase signaling and the formation of certain substances, such as PGE2, that are associated with minor pain. Clinical testing suggests that Kaprex may offer a high degree of predicted cardiovascular, gastric, renal, and liver safety.
Provides effective joint relief that is worry-free.
Modulates prostaglandin E2 (PGE2) production at specific target cells.
Features selective kinase response modulators (SKRMs) in the form of tetrahydro-iso-alpha acids (THIAA) to modulate kinase activity in favor of good health.
The ingredient synergy of Tetrase®, oleanolic acid, and rosemary provide efficacy at a low dose for a maximum cost-effectiveness.
<h6><em>This product has not been evaluated by the FDA. This product is not intended to diagnose, cure, treat or prevent any disease.</em></h6>